Marcus Heed

I'm a man working with disabled in Gothenburg. I'm a Mystic and own shares in Cereno Scientific.

[Hemostasis Today @HemostasisToday]

The Promise of Smarter Antithrombotic Therapy with Cereno Scientific - @AEjlegard

@cernoscientific @UMich

https://t.co/SoyEDSKPnO

#HemostasisToday

[BioStock @BioStock_SWE]

Cereno Scientific planerar att initiera prekliniska sjukdomsmodellstudier med kandidaten CS585 vid antifosfolipidsyndrom, en sällsynt autoimmun sjukdom som orsakar återkommande blodproppar och allvarliga kardiovaskulära komplikationer. https://t.co/M0nKgFLINp

[GU Ventures @GUVentures]

🤝Vårt portföljbolag Cereno Scientific stärker patientperspektivet inom läkemedelsutveckling för pulmonell hypertension genom samarbete med PHA Europe & Global💡

#pulmonellhypertension #lifescience #innovation #CerenoScientific #GUVentures
https://t.co/HWv60SUKfe

[BioStock @BioStock_SWE]

Cereno Scientific har ingått ett samarbete med PHA Europe & Global, en paraplyorganisation som representerar mer än 40 nationella patientföreningar. https://t.co/fUUTJePHtM

[Edison @Edison_Inv_Res]

Cereno Scientific — Long-term EAP data confirms CS1’s safety

Cereno Scientific has reported encouraging initial observations from the 12-month Expanded Access Program (EAP)… @CerenoSciAB $CRNO

📖 Full analysis: https://t.co/wvLqV7xb0i

[Marcus Heed @Slottskogsgatan]

@opsylojay1 The nordic countrys top the happy people index to! 🤓

[GU Ventures @GUVentures]

Cereno Scientific tar ett viktigt steg i utvecklingen av nästa generations behandlingar för patienter med sällsynta hjärt- och lungsjukdomar💊✨
https://t.co/xdjJbC4FwD

[Investor Studios @Investorstudios]

Ni missar väl inte dagens Market Update? 👀

Cereno Scientific, som önskats fram av programmets tittare, gästar studion och intervjuas live!

Frågor går att ställa i chatten, live 11.00 👇👇
https://t.co/P6SVlPk7wS

#Finanstwitter #PrataPengar #fintwitt

[Marcus Heed @Slottskogsgatan]

Golden Cross iaf på veckografen på Cereno Scientific #CRNO @CerenoSciAB $CRNO lite skönt när man är all in 🤓

[Edison @Edison_Inv_Res]

Cereno Scientific — CMD reaffirms shifting focus to clinical delivery

Cereno Scientific’s recent capital markets day (CMD) centered on CS1’s progression from early clinical validation into Phase IIb development… @CerenoSciAB $CRNO-B

📖 Full analysis: https://t.co/WjsHGq7OIz

[European Biotech @EuroBiotechNews]

Cereno widens clinical program as competition heats up in lung disease
https://t.co/GVlJ6pnAZL

Swedish biotech Cereno Scientific today announced the expansion of its clinical development program for its investigational small-molecule therapy, CS014, targeting rare lung d...

[Marcus Heed @Slottskogsgatan]

@realDonaldTrump @POTUS Why not just stockpile rare earth minerals!!!

https://t.co/PyiVFItXzD

[Edison @Edison_Inv_Res]

Cereno Scientific — Entering a value inflection phase

We refresh our investment case for Cereno Scientific as the company enters a key value inflection period... #OMX $CRNO-B

📖 Read the full report here: https://t.co/6NnsuYq56q

[Business-News-Today.com @cricket_fundas]

Cereno Scientific’s CS014 shows antithrombotic effect without bleeding risk in new HDAC study https://t.co/8KbISrD3FX #CerenoScientific #PharmaNews #PulmonaryFibrosis #CardiopulmonaryHealth #Epigenetics #HDACInhibitors #Thrombosis #FibrosisResearch #DrugDevelopment #clinicaltrials

[Pulmonary Hypertension News @PulmonaryNews]

Cereno Scientific is seeking FDA clearance to launch a global clinical trial testing its CS1 therapy for pulmonary arterial hypertension. https://t.co/upYoiyGADQ

#PulmonaryHypertension #PulmonaryHypertensionNews #PH #PHNews #Bionews

[Crwe World @CrweWorld]

Cereno Scientific Submits Phase IIb Trial Protocol for CS1 in Pulmonary Arterial Hypertension (PAH) to the U.S. FDA #CerenoScientific, #Cereno, #CRNOB https://t.co/X4wWkIhnDa

[TechInnovation @TechInnovationz]

$IonQ Expands Nordic Presence in Life Sciences Innovation

At NLS Days 2025 in Gothenburg, Lorenzo Roversi (IonQ) joined the panel “Gothenburg’s Global Entrepreneurs” alongside leaders from Cereno Scientific, LuceroBio, and OnDosis.

The discussion focused on how pioneering technologies scale globally, highlighting IonQ’s growing involvement in quantum applications for biotech and life sciences a key step in bridging quantum computing and medical innovation across Europe.

Link: https://t.co/rv9CQIaHMx

#IonQ #QuantumComputing #LifeScience #NLSDays #Biotech #Innovation #Sweden #QAlliance

[In Vivo, Citeline Commercial @INVIVOnow]

Podcast: Cereno Scientific Turns To Old Drug For Rare Cardiopulmonary Diseases — Click the image below to read more! || #InVivo | Start your free trial today: https://t.co/l8WABoJGmx https://t.co/M1nFaFL9gK

[PressReleaseCC @PressRelease_cc]

Chronic Pulmonary Hypertension Market Report 2034: Epidemiology, Pipeline Therapies, and Recent Regulatory Approvals by DelveInsight | Featuring Bayer, Attgeno AB, Cereno Scientific AB, Bial – Portela https://t.co/oX4jFpGKsX

[Marcus Heed @Slottskogsgatan]

@CapitalShipyard You can with out problems invest 1% of Your money in Cereno Scientific I’m 100% in but its a calculated risk! 🤓